TD Private Client Wealth’s Labcorp LH Stock Holding History

TD Private Client Wealth’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$405K	Sell	1,519 -168	-10%	-$45.5K	0.01%	517
2025 Q4	$423K	Sell	1,687 -584	-26%	-$155K	0.01%	509
2025 Q3	$652K	Sell	2,271 -2,874	-56%	-$770K	0.01%	434
2025 Q2	$1.35M	Buy	5,145 +134	+3%	+$32.6K	0.03%	302
2025 Q1	$1.17M	Buy	5,011 +379	+8%	+$92K	0.03%	314
2024 Q4	$1.06M	Sell	4,632 -185	-4%	-$42.4K	0.03%	349
2024 Q3	$1.08M	Sell	4,817 -643	-12%	-$141K	0.03%	354
2024 Q2	$1.11M	Sell	5,460 -490	-8%	-$99.7K	0.04%	330
2024 Q1	$1.3M	Buy	+5,950	New	+$1.31M	0.04%	313
2020 Q1	–	Sell	-1,124	Closed	-$163K	–	1112
2019 Q4	$163K	Buy	+1,124	New	+$162K	0.01%	473

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TD Private Client Wealth's LH Position: Q1 2026 in Review

TD Private Client Wealth reduced its Labcorp (LH) stake by 10% in Q1 2026, selling an estimated $45.5K and leaving 1,519 shares worth $405K. The position accounts for 0.01% of the portfolio, ranked #517.

TD Private Client Wealth first reported a position in LH in Q4 2019 and has held it in 10 quarters since. The position peaked at $1.35M in Q2 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

TD Private Client Wealth held 1,519 shares of Labcorp worth $405K as of Q1 2026.
TD Private Client Wealth sold 168 Labcorp shares in Q1 2026, an estimated $45.5K.
Labcorp made up 0.01% of TD Private Client Wealth's portfolio in Q1 2026, its #517 holding.
TD Private Client Wealth first reported a position in Labcorp in Q4 2019 and has held it in 10 quarters since.
TD Private Client Wealth's Labcorp position peaked at $1.35M in Q2 2025.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.